Recent Articles:
Quantitative Analysis of Circulating Cell-Free DNA for Correlation with Lung Cancer Survival: A Systematic Review and Meta-Analysis
Journal of Thoracic Oncology Volume 12, Issue 1, January 2017, Pages 43-53
Plasma cell-free DNA level and its integrity as biomarkers to distinguish non-small cell lung cancer from tuberculosis
Clinica Chimica Acta Available online 4 November 2017
Myriad Applications of Circulating Cell-Free DNA in Precision Organ Transplant Monitoring
Annals of the American Thoracic Society Vol. 14, No. Supplement_3 | Sep 01, 2017
Clinical utility of circulating cell-free DNA in advanced colorectal cancer
PLoS ONE 12(8): e0183949
The role of cell-free DNA in predicting colorectal cancer prognosis
Expert Review of Gastroenterology & Hepatology Vol. 0 , Iss. 0,0
Cell-Free Circulating DNA Integrity Based on Peripheral Blood as a Biomarker for Diagnosis of Cancer: A Systematic Review
Cell-Free DNA Promoter Hypermethylation as Blood-Based Markers for Pancreatic
Adenocarcinoma
Ph.d.-serien for Det Sundhedsvidenskabelige Fakultet, Aalborg
Universitet, DOI: 10.5278/vbn.phd.med.00083
Advances in liquid biopsy
AJCR（ISSN 2572-5769）
Tech times - Liquid Biopsy
MIT Technology Review - Liquid Biopsy
Web Sites with Useful General Information
NPR - National Public Radio - Information about Prenatal Genetic Testing
NHGRI - National Human Genome Research Institute - Circulating Tumor DNA
NIH Press Release regarding Circulating Tumor DNA
Tim Forshew - Excellent Lecture on the uses of ctDNA
References:
Non-Invasive Prenatal Diagnosis (NIPT)
with Cell Free Fetal DNA
Y
M Dennis Lo, Noemi Corbetta, Paul F Chamberlain, Vik Rai, Ian L Sargent,
Christopher W GRedman, James S Wainscoat (1997)
Presence of fetal DNA in
maternal plasma and serum. The Lancet, 350 • August 16, 1997 485-487Lo, E. S.; Lo, Y. M.;
Hjelm, N. M.; Thilaganathan, B. (1998).
Transfer of nucleated maternal cells
into fetal circulation during the second trimester of pregnancy. British Journal of Haematology 100 (3): 605-606.Lo, Y. M., et al.
(1999).
Rapid clearance of fetal DNA from maternal plasma" American Journal of Human Genetics 64 (1): 218-224.
Cell Free Circulating Tumor (ctDNA)
Cancer Applications
Schwarzenbach,
H.; Hoon, D.S.; Pantel, K. Cell-free nucleic acids as biomarkers in cancer
patients. Nat. Rev. Cancer 2011, 11, 426–437
Schwarzenbach,
H.; Circulating nucleic acids as biomarkers in breast cancer, Breast Cancer
Res. 2013; 15(5): 211
Goebel, G.; Zitt, M.;
Zitt, M.; Müller, H.M. Circulating nucleic acids in plasma or serum (CNAPS) as
prognostic and predictive markers in patients with solid neoplasias. Dis. Markers 2005, 21, 105–120.
Figg,
W.D.; Reid, J. Monitor tumor burden with circulating tumor DNA. Cancer Biol. Ther. 2013, 14, 697–698.
Jin,
D.; Xie, S.; Mo, Z.; Liang, Y.; Guo, B.; Yu, M. Circulating DNA-important
biomarker of cancer. J. Mol.
Biomarkers Diagn. 2012,
doi:10.4172/2155-9929.S2-009
Gormally,
E.; Caboux, E.; Vineis, P.; Hainaut, P. Circulating free DNA in plasma or serum
as biomarker of carcinogenesis: Practical aspects and biological significance. Mutat. Res. 2007, 635, 105–117.
Holdenrieder, S.; Nagel,
D.; Schalhorn, A.; Heinemann, V.; Wilkowski, R.; von Pawel, J.; Raith, H.;
Feldmann, K.; Kremer, A.E.; Müller, S.; et
al. Clinical relevance of circulating nucleosomes in cancer. Ann. N. Y. Acad. Sci. 2008, 1137, 180–189.
Beck, J.; Urnovitz, H.B.;
Riggert, J.; Clerici, M.; Schütz, E. Profile of the circulating DNA in
apparently healthy individuals. Clin.
Chem. 2009, 55, 607–608.
Elshimali, Y;
Khaddour, H; Sarkissyan, M; Wu, Y; Vadgama, J. The Clinical Utilization of
Circulating Cell Free DNA (CCFDNA) in Blood of Cancer Patients Int. J. Mol.
Sci. 2013, 14, 18925-18958.
Hong Yuen Wong and Ben Ho Park , Ann Transl Med. 2014 Jan; 2(1): 2.
E Crowley, F Di Nicolantonio, F Loupakis & A Bardelli , Nature Reviews Clinical Oncology 10, 472-484 (August 2013) |doi:10.1038/nrclinonc.2013.110
